Scientific Considerations in Demonstrating Biosimilarity to a Reference Product: Updated Recommendations for Assessing the Need for Comparative Efficacy Studies: Draft Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
October 29, 2025
October 29, 2025
e314875c-585b-4d6e-bb97-b1b4f4edc32d
Related Documents
Biosimilar and Interchangeable Biosimilar Products: Considerations for Container Closure Systems and Device Constituent Parts
Guidance DocumentJuly 31, 2026Center for Drug Evaluation and Research
Pediatric Drug Development Under the Pediatric Research Equity Act and the Best Pharmaceuticals for Children Act: Scientific Considerations
Guidance DocumentMay 17, 2023Center for Drug Evaluation and Research
Considerations in Demonstrating Interchangeability With a Reference Product: Update
Guidance DocumentJune 21, 2024Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.